Assuming that no other shared genetic and familial risk factors besides BRCA1/2 PVs exist between PCa, breast and ovarian cancer, such ascertainment should in principle not introduce ascertainment bias. This evidence concerns the gene BRCA1 and ovarian carcinoma.